Shopping Cart
- Remove All
- Your shopping cart is currently empty
Mopidamol (RA 233) is a phosphodiesterase inhibitor, a dipyridamole derivative, with anticancer activity that prevents retinal vascular defects in experimental diabetes.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $380 | In Stock | |
5 mg | $889 | In Stock | |
10 mg | $1,230 | In Stock | |
25 mg | $1,830 | In Stock | |
50 mg | $2,180 | In Stock | |
100 mg | $2,800 | In Stock |
Description | Mopidamol (RA 233) is a phosphodiesterase inhibitor, a dipyridamole derivative, with anticancer activity that prevents retinal vascular defects in experimental diabetes. |
Targets&IC50 | Lipid peroxidation:89 μmol/L |
Alias | Rapenton, RA-233, RA233, RA 233, OLX 102 |
Molecular Weight | 421.49 |
Formula | C19H31N7O4 |
Cas No. | 13665-88-8 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 50 mg/mL (118.63 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.